FIELD: medicine.
SUBSTANCE: invention refers to medicine, and can be applied for treating stretch marks. It involves injections of cytapheresis produced peripheral blood self-cell suspension in the concentration of 109 cell/ml in the area of skin defects. The suspension is injected in the stretch mark thickness by 0.03-0.05 ml, every 5-10 mm in extended stretch marks or in one point directly in the atrophic regions, in smaller stretch marks of the length less than 5 mm.
EFFECT: method allows to stimulate neoangiogenesis, to accelerate stretch marks elimination.
2 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF DERMAL STRETCH MARKS | 2006 |
|
RU2338562C2 |
METHOD FOR TRANSPLANTATION OF PERIPHERAL BLOOD AUTOLOGOUS HAEMOPOIETIC STEM CELLS | 2019 |
|
RU2734121C1 |
SKIN REPAIR METHOD | 2019 |
|
RU2731313C1 |
METHODS FOR PRODUCING COSMETIC COMPOSITION CONTAINING LEUKOLECTIN AND USE THEREOF | 2012 |
|
RU2595823C2 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF ECZEMA IN PATIENTS SUFFERING ACCOMPANIED CHRONIC GASTRODUODENITIS | 2011 |
|
RU2461836C1 |
TETRAPEPTIDES OBTAINED FROM HUMAN SYNTHETIC CHEMICALS SUITABLE FOR TREATING DIFFERENT SKIN CONDITIONS | 2014 |
|
RU2687151C2 |
IMPLANTED NEUROENDOPROSTHETIC SYSTEM, METHOD OF OBTAINING IT AND METHOD OF CARRYING OUT RECONSTRUCTIVE NEUROSURGICAL OPERATION | 2008 |
|
RU2394593C2 |
METHOD OF PREDICTING DEVELOPMENT OF SCARS AFTER PREVIOUS ACNE | 2009 |
|
RU2415647C2 |
METHOD FOR UNRESTRICTED FREEZING PERIPHERAL BLOOD PRECURSOR CELLS AT MINUS 80 °C UNDER PROTECTION OF DIMETHYLSULPHOXID | 2018 |
|
RU2707921C1 |
METHOD OF TREATING T-CELL LYMPHOMAS AND KAPOSIS'S SARCOMA | 2009 |
|
RU2401671C1 |
Authors
Dates
2010-12-27—Published
2009-10-21—Filed